Vigabatrin Tablet shortage
To Be Discontinued 1 presentations · 1 manufacturers · first FDA posting Oct 16, 2026 · last update Oct 16, 2026
Manufacturers: Hikma Pharmaceuticals USA, Inc.
Stated reasons (per FDA): Not stated (FDA did not give a reason)
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Vigabatrin, Tablet, 500 mg (NDC 0054-0652-25) | Hikma Pharmaceuticals USA, Inc. | To Be Discontinued | — | The decision to discontinue this drug product was due to a business decision and not due to any reasons of safety or effectiveness. | Posted Oct 16, 2026 Updated Oct 16, 2026 Discontinued Oct 16, 2026 |